Wegovy vs Saxenda: Weekly or Daily, and the Price Gap
Wegovy (semaglutide, Novo Nordisk) vs Saxenda (liraglutide, Novo Nordisk)
Last verified November 2026
The verdict
Both come from Novo Nordisk, both are for weight management, and Saxenda is the older drug in every sense. Liraglutide's ~13-hour half-life forces daily injection where semaglutide's ~7 days allows weekly. Wegovy has SELECT and its MACE −20%; Saxenda has no dedicated obesity outcomes trial, only LEADER's −13% at a diabetes dose. The commercial gap is stark: $349 a month through NovoCare against well over $1,000 at retail for Saxenda, with no comparable cash program. There are few arguments left for Saxenda.
Side-by-side comparison
| Field | Wegovy | Saxenda |
|---|---|---|
| Head-to-head (STEP-8, 68 weeks) | -15.8% body weight (semaglutide 2.4 mg weekly) | -6.4% body weight (liraglutide 3.0 mg daily) |
| Mechanism | GLP-1 receptor agonist (long-acting, ~7-day half-life) | GLP-1 receptor agonist (short-acting, ~13-hour half-life) |
| Dosing frequency | Once-weekly subcutaneous injection | Once-daily subcutaneous injection |
| Whether a trial proved it prevents heart attacks and strokes | SELECT cut major cardiac events 20% in obesity without diabetes | No trial at this dose. LEADER cut them 13% at the 1.8 mg diabetes dose of the same molecule |
| Weight lost in the pivotal trial | -14.9% over 68 weeks (STEP-1) | -8.0% over 56 weeks (SCALE Obesity) |
| What it costs if you pay cash | $349/mo via NovoCare ($199 for the first two fills for new patients) | About $1,349/mo list, with no comparable program |
| What it is approved to treat | Long-term weight management, plus reducing cardiac risk since March 2024 | Long-term weight management, in adults and from age 12 |
| Youngest approved age | 12 and over, approved December 2022 | 12 and over, approved December 2020, at a body weight above 60 kg |
What each one costs in the compounded market
Standing monthly cash prices from the 734 sellers on this register. These are compounded preparations, not the approved products compared above.
Wegovy — semaglutide
from $47 /mo
463 sellers publish a standing price. This is the lowest of all 463; the median is $174 a month.
Where to get semaglutide — a selection of sellers, not a price ranking
- Embody review$79/mo
- SnagRx review$99/mo
- Collective review$59/mo + membership
Saxenda — liraglutide
from $149 /mo
5 sellers publish a standing price. This is the lowest of all 5; the median is $160 a month.
Where to get liraglutide — a selection of sellers, not a price ranking
- Factor Health MD review$150/mo
- Bloom MD review$395/mo
- Alloy review$214/mo
⚠ A compounded preparation is not the approved product. No agency has reviewed that specific preparation for safety, effectiveness or manufacturing quality, and the legal ground under compounding these molecules narrowed when the shortages closed. The price gap is real, and so is the difference in oversight. Every seller, with its price record.
Frequently asked questions
Are Wegovy and Saxenda the same drug?
No. Wegovy is semaglutide and Saxenda is liraglutide — different molecules, and they work differently: GLP-1 receptor agonist (long-acting, ~7-day half-life) against GLP-1 receptor agonist (short-acting, ~13-hour half-life). Results with one do not predict results with the other.
Is Wegovy or Saxenda cheaper?
On the manufacturers' own cash pricing: Wegovy at $349/mo via NovoCare ($199 for the first two fills for new patients), Saxenda at About $1,349/mo list, with no comparable program. That is the list-price comparison, and it is not what most people pay. What you actually pay depends on whether your plan covers it, which formulary tier it sits in, and whether you have met your deductible — and for many people the honest comparison is between an insured copay and a cash-pay compounded alternative rather than between these two figures.
How is each one taken?
Wegovy: Once-weekly subcutaneous injection. Saxenda: Once-daily subcutaneous injection. Worth weighing honestly against your own habits — the best drug for you is partly the one you will still be taking in eight months, and a dosing routine that does not fit a life gets abandoned.
What does a compounded version of each actually cost?
Across the 734 sellers in this register, the cheapest standing monthly cash prices we hold are semaglutide from $47 a month and liraglutide from $149 a month. A compounded preparation is not the approved product: no agency has reviewed that specific preparation for safety, effectiveness or manufacturing quality, and the legal ground under compounding these molecules narrowed once the shortages closed. The price gap is real and so is the difference in oversight.
Can I switch from Wegovy to Saxenda?
Yes, with a prescriber. Expect to re-titrate from the bottom of the new drug's ladder rather than starting where you left off: these are different molecules and tolerance to one does not transfer to the other. Both the old drug's washout and the new drug's schedule apply.
Which one should I ask for?
That is a prescriber's call, and anyone answering it from a table is guessing. What a page like this can do is tell you what the trials measured, what the manufacturers charge, and where the evidence is still missing, so the conversation starts from the record rather than from an advertisement.
References
- 1.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021. PMID: 33567185.
- 2.Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity and Prediabetes). N Engl J Med. 2015. PMID: 26132939.
- 3.Rubino DM, Greenway FL, Khalid U, et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes (STEP 8): A Randomized Clinical Trial. JAMA. 2022. PMID: 35015037.
- 4.Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes (SELECT). N Engl J Med. 2023. PMID: 37952131.
- 5.Novo Nordisk. WEGOVY (semaglutide) injection — FDA prescribing information. DailyMed (NIH/NLM). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- 6.Novo Nordisk. SAXENDA (liraglutide) injection — FDA prescribing information. DailyMed (NIH/NLM). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
- 7.Marso SP, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes N Engl J Med. 2016. PMID: 27295427.
Related comparisons
- Saxenda vs Ozempic
- Wegovy vs Ozempic
- Trulicity vs Wegovy
- Saxenda vs Zepbound
- Saxenda vs Foundayo
- Mounjaro vs Saxenda
See the full drug-vs-drug verdict index or provider rankings.